Interactions of human organic anion transporters with diuretics

被引:151
|
作者
Hasannejad, H
Takeda, M
Taki, K
Shin, HJ
Babu, E
Jutabha, P
Khamdang, S
Aleboyeh, M
Onozato, ML
Tojo, A
Enomoto, A
Anzai, N
Narikawa, S
Huang, XL
Niwa, T
Endou, H
机构
[1] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 1818611, Japan
[2] Nagoya Univ, Sch Med, Dept Clin Prevent Med, Nagoya, Aichi 466, Japan
[3] Univ Tokyo, Dept Nephrol & Endocrinol, Tokyo, Japan
[4] Fuji Biomedixs Co, Kobuchizawa Labs, Yamanashi, Japan
来源
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2004年 / 308卷 / 03期
关键词
D O I
10.1124/jpet.103.059139
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The tubular secretion of diuretics in the proximal tubule has been shown to be critical for the action of drugs. To elucidate the molecular mechanisms for the tubular excretion of diuretics, we have elucidated the interactions of human organic anion transporters (hOATs) with diuretics using cells stably expressing hOATs. Diuretics tested were thiazides, including chlorothiazide, cyclothiazide, hydrochlorothiazide, and trichlormethiazide; loop diuretics, including bumetanide, ethacrynic acid, and furosemide; and carbonic anhydrase inhibitors, including acetazolamide and methazolamide. These diuretics inhibited organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4 in a competitive manner. hOAT1 exhibited the highest affinity interactions for thiazides, whereas hOAT3 did those for loop diuretics. hOAT1, hOAT3, and hOAT4 but not hOAT2, mediated the uptake of bumetanide. hOAT3 and hOAT4, but not hOAT1 mediated the efflux of bumetanide. hOAT1 and hOAT3, but not hOAT2 and hOAT4 mediated the uptake of furosemide. In conclusion, it was suggested that hOAT1 may play an important role in the basolateral uptake of thiazides, and hOAT3 in the uptake of loop diuretics. In addition, it was also suggested that bumetanide taken up by hOAT3 and/or hOAT1 is excreted into the urine by hOAT4.
引用
收藏
页码:1021 / 1029
页数:9
相关论文
共 50 条
  • [41] Endocrine regulation of rat organic anion transporters
    Buist, SCN
    Cherrington, NJ
    Klaassen, CD
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 559 - 564
  • [42] Regulation of hepatic organic anion transporters by cytokines
    Geier, A
    Matern, S
    Gartung, C
    CYTOKINES IN LIVER INJURY AND REPAIR, 2002, 125 : 201 - 203
  • [43] Drug transport by Organic Anion Transporters (OATs)
    Burckhardt, Gerhard
    PHARMACOLOGY & THERAPEUTICS, 2012, 136 (01) : 106 - 130
  • [44] Update on the molecular physiology of organic anion transporters
    Ahn, Sun-Young
    Bhatnagar, Vibha
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2008, 17 (05): : 499 - 505
  • [45] Novel aspects of renal organic anion transporters
    Eraly, SA
    Blantz, RC
    Bhatnagar, V
    Nigam, SK
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (05): : 551 - 558
  • [46] Chaperoning organic anion transporters through the hepatocyte
    Wolkoff, A. W.
    Wang, P.
    Nath, S.
    Sarkar, S.
    Murray, J. W.
    FUTURE PERSPECTIVES IN GASTROENTEROLOGY, 2008, 161 : 66 - 76
  • [47] Recent Advances on the Regulations of Organic Anion Transporters
    Yu, Zhou
    You, Guofeng
    PHARMACEUTICS, 2024, 16 (11)
  • [48] Molecular pharmacology of renal organic anion transporters
    Van Aubel, RAMH
    Masereeuw, R
    Russel, FGM
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (02) : F216 - F232
  • [49] Structure of renal organic anion and cation transporters
    Burckhardt, G
    Wolff, NA
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (06) : F853 - F866
  • [50] Thyroid hormone and organic anion transporters in brain
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    NEUROSCIENCE RESEARCH, 2006, 55 : S47 - S47